Literature DB >> 11341925

Xanthine dehydrogenase from Pseudomonas putida 86: specificity, oxidation-reduction potentials of its redox-active centers, and first EPR characterization.

K Parschat1, C Canne, J Hüttermann, R Kappl, S Fetzner.   

Abstract

Xanthine dehydrogenase (XDH) from Pseudomonas putida 86, which was induced 65-fold by growth on hypoxanthine, was purified to homogeneity. It catalyzes the oxidation of hypoxanthine, xanthine, purine, and some aromatic aldehydes, using NAD+ as the preferred electron acceptor. In the hypoxanthine:NAD+ assay, the specific activity of purified XDH was 26.7 U (mg protein)(-1). Its activity with ferricyanide and dioxygen was 58% and 4%, respectively, relative to the activity observed with NAD+. XDH from P. putida 86 consists of 91.0 kDa and 46.2 kDa subunits presumably forming an alpha4beta4 structure and contains the same set of redox-active centers as eukaryotic XDHs. After reduction of the enzyme with xanthine, electron paramagnetic resonance (EPR) signals of the neutral FAD semiquinone radical and the Mo(V) rapid signal were observed at 77 K. Resonances from FeSI and FeSII were detected at 15 K. Whereas the observable g factors for FeSII resemble those of other molybdenum hydroxylases, the FeSI center in contrast to most other known FeSI centers has nearly axial symmetry. The EPR features of the redox-active centers of P. putida XDH are very similar to those of eukaryotic XDHs/xanthine oxidases, suggesting that the environment of each center and their functionality are analogous in these enzymes. The midpoint potentials determined for the molybdenum, FeSI and FAD redox couples are close to each other and resemble those of the corresponding centers in eukaryotic XDHs.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11341925     DOI: 10.1016/s0167-4838(00)00214-4

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  7 in total

1.  The impact of single nucleotide polymorphisms on human aldehyde oxidase.

Authors:  Tobias Hartmann; Mineko Terao; Enrico Garattini; Christian Teutloff; Joshua F Alfaro; Jeffrey P Jones; Silke Leimkühler
Journal:  Drug Metab Dispos       Date:  2012-01-25       Impact factor: 3.922

2.  Transcriptional activation of quinoline degradation operons of Pseudomonas putida 86 by the AraC/XylS-type regulator OxoS and cross-regulation of the PqorM promoter by XylS.

Authors:  Birgit Carl; Susanne Fetzner
Journal:  Appl Environ Microbiol       Date:  2005-12       Impact factor: 4.792

3.  SAR202 Genomes from the Dark Ocean Predict Pathways for the Oxidation of Recalcitrant Dissolved Organic Matter.

Authors:  Zachary Landry; Brandon K Swan; Gerhard J Herndl; Ramunas Stepanauskas; Stephen J Giovannoni
Journal:  mBio       Date:  2017-04-18       Impact factor: 7.867

4.  Site directed mutagenesis of amino acid residues at the active site of mouse aldehyde oxidase AOX1.

Authors:  Silvia Schumann; Mineko Terao; Enrico Garattini; Miguel Saggu; Friedhelm Lendzian; Peter Hildebrandt; Silke Leimkühler
Journal:  PLoS One       Date:  2009-04-29       Impact factor: 3.240

5.  Structural data on the periplasmic aldehyde oxidoreductase PaoABC from Escherichia coli: SAXS and preliminary X-ray crystallography analysis.

Authors:  Ana Rita Otrelo-Cardoso; Márcia Alexandra da Silva Correia; Viola Schwuchow; Dmitri I Svergun; Maria João Romão; Silke Leimkühler; Teresa Santos-Silva
Journal:  Int J Mol Sci       Date:  2014-01-31       Impact factor: 5.923

6.  Blackberry Leaves as New Functional Food? Screening Antioxidant, Anti-Inflammatory and Microbiological Activities in Correlation with Phytochemical Analysis.

Authors:  Magdalena Paczkowska-Walendowska; Anna Gościniak; Daria Szymanowska; Dominik Szwajgier; Ewa Baranowska-Wójcik; Piotr Szulc; Dagna Dreczka; Marek Simon; Judyta Cielecka-Piontek
Journal:  Antioxidants (Basel)       Date:  2021-12-04

7.  Lichen-Derived Compounds and Extracts as Biologically Active Substances with Anticancer and Neuroprotective Properties.

Authors:  Elżbieta Studzińska-Sroka; Aleksandra Majchrzak-Celińska; Przemysław Zalewski; Dominik Szwajgier; Ewa Baranowska-Wójcik; Barbara Kaproń; Tomasz Plech; Marcin Żarowski; Judyta Cielecka-Piontek
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.